ADIPOQ and Abdominal obesity: Low adiponectin levels are observed in obese subjects with and without severe coronary atherosclerosis and in subjects with abdominal obesity [10, 25], and decreased adiponectin levels (<4 μg/mL) are associated with a twofold increase in the prevalence of coronary heart disease, independent of other cardiovascular risk factors [26].